Open-label, Single Arm, Interventional Study to Explore the Efficacy and Safety of Paliperidone ER in the Management of Patients With Acute Agitation and/or Aggression.
Phase of Trial: Phase IV
Latest Information Update: 18 Feb 2016
At a glance
- Drugs Paliperidone (Primary) ; Benzodiazepines
- Indications Aggression; Agitation
- Focus Therapeutic Use
- Acronyms IMPACT
- Sponsors Janssen-Cilag
- 20 Dec 2012 Actual initiation date changed from 1 Jan 2010 to 1 Mar 2010 as reported by ClinicalTrials.gov record.
- 19 Mar 2012 Actual patient number (56) added as reported by ClinicalTrials.gov.
- 19 Mar 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.